Company page
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is a public company traded under the ticker ACRV in the American market. The company has a market capitalization of approximately $67.2 million. Acrivon focuses on developing innovative therapies to improve patient outcomes in various diseases.
- Ticker
- ACRV:NASDAQ
- Asset type
- Stock
- Market cap
- $67.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD